Anti-Human FGFR4 Therapeutic Antibody
Recombinant Humanized monoclonal antibody expressed in CHO binding to Human FGFR4. The FGFR4 antibodiess are suitable for diagnosing, preventing and/or treatment of diseases associated with FGFR4 expression. FGFR4 has been found to be expressed and/or influencing prognostic outcome in several types of cancer such as melanoma, breast, prostate, thyroid and pancreatic cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-286CL |
| Pricing | Inquiry |
| Type | Antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |
| Target | FGFR4 |
| Species Reactivity | Human |